Clorox (NYSE:CLX) Price Target Raised to $100.00

Clorox (NYSE:CLX) had its price target lifted by UBS Group from $96.00 to $100.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a neutral rating on the stock.

A number of other analysts also recently commented on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. BNP Paribas Exane dropped their price target on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research report on Tuesday, May 12th. Barclays cut their price target on Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Evercore reiterated an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $103.47.

Clorox Price Performance

CLX stock opened at $96.13 on Thursday. The firm has a 50 day moving average of $94.59 and a 200-day moving average of $104.01. Clorox has a 12-month low of $84.70 and a 12-month high of $132.03. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The company has a market cap of $11.62 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 0.46 and a beta of 0.54.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts expect that Clorox will post 5.52 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Large investors have recently made changes to their positions in the stock. Caitlin John LLC raised its stake in Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares during the last quarter. Darwin Wealth Management LLC purchased a new position in Clorox in the 2nd quarter valued at about $29,000. Vision Financial Markets LLC boosted its stake in shares of Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the last quarter. Root Financial Partners LLC boosted its stake in shares of Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after purchasing an additional 145 shares during the last quarter. Finally, SHP Wealth Management purchased a new stake in shares of Clorox during the fourth quarter worth about $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.